Abstract
More than 400 compounds isolated from soil microorganisms, and catalogued in the antibiotic library of the Kitasato Institute for Life Sciences, were screened against African trypanosomes. Ten compounds were found to have selective and potent antitrypanosomal activity in vitro: aureothin, cellocidin, destomycin A, echinomycin, hedamycin, irumamycin, LL-Z 1272β, O-methylnanaomycin A, venturicidin A and virustomycin A. Results of the in vitro assays using the GUTat 3.1 strain of Trypanosomal brucei brucei and the STIB900 strain of T. b. rhodesiense are presented. Cytotoxicity was determined using a human MRC-5 cell line. This is the first report of antitrypanosomal activities of the 10 microbial metabolites listed above.
Similar content being viewed by others
Article PDF
References
WHO. Human African trypanosomiasis (sleeping sickness): epidemiological update. Weekly Epidemiol Rec 81: 71–80 ( 2006)
Milord F, Pépin J, Loko L, Ethier L, Mpia B . Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness. Lancet 340: 652–655 ( 1992)
Fairlamb AH . Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parasitol 19: 488–494 ( 2003)
Yabu T, Koide T, Ohta N, Nose M, Ogihara Y . Continuous growth of bloodstream forms of Trypanosoma brucei brucei in axenic culture system containing a low concentration of serum. Southeast Asian J Trop Med Public Health 29: 591–595 ( 1998)
Baltz T, Baltz D, Giroud Ch, Crockett J . Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J 4: 1273–1277 ( 1985)
Räz B, Iten M, Grether-Buhler Y, Kaminsky R, Brun R . The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense) in vitro. Acta Trop 68: 139–147 ( 1997)
Tasdemir D, Kaiser M, Brun R, Yardley V, Schmidt TJ, Tosun F, Rüedi P . Antitrypanosomal and antileishmanial activites of flavoids and their analogues: In vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies. Antimicrob Agents Chemother 50: 1352–1364 ( 2006)
Otoguro K, Kohana A, Manabe C, Ishiyama A, Ui H, Shiomi K, Yamada H, Ōmura S . Potent antimalarial activities of polyether antibiotic, X-206. J Antibiot 54: 658–663 ( 2001)
Bacchi CJ, Brun R, Croft SL, Alicea K, Bühler Y . In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors. Antimicrob Agents Chemother 40: 1448–1453 ( 1996)
Washizu F, Umezawa H, Sugiyama N . Chemical studies on a toxic product of Streptomyces thioluteus, auteothin. J Antibiot 7A: 60 ( 1954)
Schmitz H, Woodside R . Aureothin, a new antifungal antibiotic. Antibiot Chemother 5: 652–657 ( 1955)
Oishi H, Hosaka T, Okutomi T, Suzuki K, Ando K . Pesticidal activity of aureothin. Agric Biol Chem 33: 1790–1791 ( 1969)
Otoguro K, Liu Z-X, Fukuda K, Li Y . Iwai Y, Tanaka H, Ōmura S. Screening for new nematocidal substances of microbial origin by a new method using the pine wood nematode. J Antibiot 41: 573–575 ( 1988)
Friedrich T, van Heek P, Leif H, Ohnishi T, Forche E, Kunze B, Jansen R, Trowitzsch-Kienast W, Hofle G, Reichenbach H, Weiss H . Two binding sites of inhibitor in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose: ubiquinone oxidoreductase. Eur J Biochem 219: 691–698 ( 1994)
Suzuki S, Nakamura G, Okuma K, Tomiyama Y . Cellocidin, a new antibiotic. J Antibiot 11: 81–83 ( 1958)
Suzuki S, Okuma K . The structure of cellocidin. J Antibiot 11: 84–86 ( 1958)
Tomomasa M . Mode of action of agricultural antibiotics developed in Japan. Residue Reviews 25: 93–106 ( 1969)
Tanaka T, Sakaguchi K, Otake N, Yonehara H . Impoved screening method for inhibitors of nucleic acid synthesis. Agric Biol Chem 32: 100–103 ( 1968)
Kondo S, Sezaki M, Koike M, Shimura M, Akita E, Satoh K, Hara T . Destomycins A and B, two new antibiotics produced by a Streptomyces. J Antibiot 18: 38–42 ( 1965)
Kondo S, Iinuma K, Naganawa H, Shimura M, Sekizawa Y . Structural studies on destomycins A and B. J Antibiot 28: 79–82 ( 1975)
Sawada I . Anthelmintic effect of destomycin A against poultry tapeworms. Jpn J Parasit 21: 45–48 ( 1972)
Kojima M, Nojiri C, Yamada Y . Studies on Mode of action of destomycin A. Meiji Seika Kenkyu Nenpo 10: 1–8 ( 1969)
Suzuki A, Ishida K . Activating effect of destomycin A on adenylate cyclase from several animal tissues. FEBS Lett 144: 326–328 ( 1982)
Katagiri K, Yoshida T, Sato K . In: Corcoran JW, Hahn FE (ed). Antibiotics III: Mechanism of Action of Antimicrobial and Antitumor Agents. Springer, Berlin, pp. 234–51 ( 1974)
Waring MJ . In: Hahn FE (ed). Antibiotics V/Part 2: Mechanism of Action of Antieukaryotic and Antiviral Compounds. Springer, Berlin, pp. 173–194 ( 1979)
Bradner WT, Heinemann B, Gourevitch A . Hedamycin, a new antitumor antibiotic. II. Biological properties. Antimicrob Agents Chemother 1966: 613–618 ( 1967)
Ui H, Ishiyama A, Sekiguchi H, Namatame M, Nisihara A, Takahashi Y, Shiomi K, Otoguro K, Ōmura S . Selective and potent in vitro antimalarial activities found in four microbial metabolites. J Antibiot 60: 220–222 ( 2007)
Ellested GA, Evans RH Jr, Kunstmann MP . Some new terpenoid metabolite from an unidentified Fusarium species. Tetrahedron 25: 1323–1334 ( 1969)
Hayakawa S, Minato H, Katagiri K . The ilicolins, antibiotics from Cylindrocladium ilicicola. J Antibiot 24: 653–654 ( 1971)
Takamatsu S, Rho M-C, Masuma R, Hayashi M, Komiyama K, Tanaka H, Ōmura S . A novel testosterone 5α-reductase inhibitor, 8′,9′-dehydroascochlorin produced by Verticillium sp. FO-2787. Chem Pharm Bull 42: 953–956 ( 1994)
Minagawa N, Yabu Y, Kita K, Nagai K, Ohta N, Meguro K, Sakajo S, Yoshimoto A . An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei. Mol Biochem Parasitol 81: 127–136 ( 1996)
Yabu Y, Minagawa N, Kita K, Nagai K, Honma M, Sakajo S, Koide T, Ohta N, Yoshimoto A . Oral and intraperitoneal treatment of Trypanosoma brucei brucei with a combination of ascofuranone and glycerol in mice. Parasitol Int 47: 131–137 ( 1998)
Tanaka H, Marumo H, Nagai T, Okada M, Taniguchi K, Ōmura S . Nanaomycins, new antibiotics produced by a strain of Streptomyces. III. A new component, nanaomycin C, and biological activities of nanaomycin derivatives. J Antibiot 28: 925–930 ( 1975)
Hayashi M, Unemoto T, Minami-Kakinuma S, Tanaka H, Ōmura S . The mode of action of nanaomycins D and A on a gram-negative marine bacterium Vibrio Alginolyticus. J Antibiot 35: 1078–1085 ( 1982)
Ōmura S, Tanaka Y, Nakagawa A, Iwai Y, Inoue M, Tanaka H . Irumamycin, a new antibiotic active against phytopathogenic fungi. J Antibiot 35: 256–257 ( 1982)
Brufani M, Keller-Schierlein W, Loeffler W, Mansperger I, Zaehner H . Metabolite products of microorganisms. LXIX. Venturicidin B, cotrycidin, and the sugar structural units of venturicidin A and B. Helv Chim Acta 51: 1293–1304 ( 1968)
Warhurst DC, Thomas SC . The chemotherapy of rodent malaria, XXXI. The effect of some metabolic inhibitors upon chloroquine-induced pigment clumping (CIPC) in Plasmodium berghei. Ann Trop Med Parasitol 72: 203–211 ( 1978)
Walter P, Lardy HA, Johnson D . Antibiotics as tools for metabolic studies. X. Inhibition of phosphoryl transfer reactions in mitochondria by peliomycin, ossamycin, and venturicidin. J Biol Chem 242: 5014–5018 ( 1967)
Unitt MD, Lloyd D . Effects of inhibitors on mitochondrial adenosine triphosphatase of T. pyriformis ST. J Gen Microbiol 126: 261–266 ( 1981)
Ōmura S, Shimizu H, Iwai Y, Hinotozawa K, Otoguro K, Hashimoto H, Nakagawa A . AM-2604 A, a new antiviral antibiotic produced by a strain of Streptomyces. J Antibiot 35: 256–257 ( 1982)
Ōmura S, Otoguro K, Tanaka H . The mode of action of a novel 18-memberd macrolide, virustomycin A (AM-2604 A), on Trichomonas foetus. J Antibiot 36: 1755–1761 ( 1983)
Berriman M, et al. The Genome of the African Trypanosome Trypanosoma brucei. Science 309: 416–435 ( 2005)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Otoguro, K., Ishiyama, A., Namatame, M. et al. Selective and Potent in Vitro Antitrypanosomal Activities of Ten Microbial Metabolites. J Antibiot 61, 372–378 (2008). https://doi.org/10.1038/ja.2008.52
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2008.52
Keywords
This article is cited by
-
Rational design of the carbonyl reductase EbSDR8 for efficient biosynthesis of enantiopure (R)-3-chloro-1-phenyl-1-propanol
Applied Microbiology and Biotechnology (2020)
-
In vitro screening of known drugs identified by scaffold hopping techniques shows promising leishmanicidal activity for suramin and netilmicin
BMC Research Notes (2018)
-
In vitro antitrypanosomal activity of the cyclodepsipeptides, cardinalisamides A–C, from the insect pathogenic fungus Cordyceps cardinalis NBRC 103832
The Journal of Antibiotics (2014)
-
Venturicidin C, a new 20-membered macrolide produced by Streptomyces sp. TS-2-2
The Journal of Antibiotics (2014)
-
Mangromicins A and B: structure and antitrypanosomal activity of two new cyclopentadecane compounds from Lechevalieria aerocolonigenes K10-0216
The Journal of Antibiotics (2014)